100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothHydralazine 37.5mg + Isosorbide Dinitrate 20mg
You Searched
Our Recommendation
Hydrozolin ISDN 20/37.5mg Tablet 10s
3,586+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Heart failure
Customers also bought
More About Irosus 20mg/37.5mg Tablet
Benefits
In Treatment of Heart failure : Heart failure means your heart is weak and cannot pump enough blood to your lungs and the rest of your body. The most common symptoms are breathlessness, tiredness, and swelling in your legs, ankles, abdomen and other parts of your body. Irosus 20mg/37.5mg Tablet makes it easier for your heart to pump blood around your body and is therefore an effective treatment for heart failure.This medicine will help relieve your symptoms, making you feel better and more energetic. You should make appropriate lifestyle changes, such as eating healthy and keeping active, to help this medicine be effective. Take it regularly and keep taking it even if you feel better.
Side Effects
Side effects of Irosus Tablet The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Irosus Headache Dizziness
How to use
How to use Irosus Tablet Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Irosus 20mg/37.5mg Tablet is to be taken with food.
How it works
How Irosus Tablet works Irosus 20mg/37.5mg Tablet is a combination of two medicines:.
Unsafe: It is unsafe to consume alcohol while taking Irosus 20mg/37.5mg Tablet , as it may lead to symptoms such as flushing, increased heart rate, nausea, thirst, chest pain, and low blood pressure, known as a Disulfiram reaction.
Irosus 20mg/37.5mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Irosus 20mg/37.5mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Irosus 20mg/37.5mg Tablet may cause side effects which could affect your ability to drive.As Irosus 20mg/37.5mg Tablet may cause headaches or lead to difficulty in concentration and this may affect your ability to drive.
Irosus 20mg/37.5mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Irosus 20mg/37.5mg Tablet may be needed. Doctor consultation is advised.Regular monitoring of blood pressure is recommended for better dose adjustment.
Irosus 20mg/37.5mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Irosus 20mg/37.5mg Tablet may not be needed in these patients. Please consult your doctor.
What if I forget to take it?
If a dose of Irosus 20mg/37.5mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Hyderabad, Telangana, India
References
Ferdinand KC, Elkayam U, Mancini D, et al. Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial. Am J Cardiol. 2014;114(1):151-9 (21 Jan. 2019)
Mastanamma SK, Saidulu P, Sravanthi A, et al. Stability Indicating Validated RP-HPLC Method for Simultaneous Determination of Hydralazine Hydrochloride and Isosorbide Dinitrate in Bulk and Pharmaceutical Dosage Form. Int J Pharm Sci Rev Res. 2016;40(1):1411-48 (21 Jan. 2019)
Cheng JW. A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination. Clin Ther. 2006;28(5):666-78 (21 Jan. 2019)
Isosorbide dinitrate and hydralazine hydrochloride. Seymour, Indiana: Kremers Urban Pharmaceuticals Inc.; 2005 (23 Jan. 2019)
Isosorbide dinitrate and hydralazine hydrochloride (28th Sept. 2023)
Central Drugs Standard Control Organization. Isosorbide Dinitrate+Hydralazine (28th Sept. 2023)
ScienceDirect. Isosorbide Dinitrate (28th Sept. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
